LabTurbo Biotech

What LabTurbo Biotech does

LabTurbo Biotech Corporation is a molecular diagnostics company that designs and manufactures fully automated instruments, PCR detection kits, and nucleic acid extraction kits for high-complexity clinical laboratories, while also operating a clinical testing services business in the United States. Its core technology centers on the AIO 48 SP-qPCR System, a sample-to-report platform that integrates barcode scanning, nucleic acid extraction, liquid handling, PCR setup, and result reporting and can process up to 48 specimens/192 wells per run with 5-channel multiplex detection. The product line extends to the QuadAIO point-of-care random-access system, the 48 Extraction System, the VacEZor manual extraction instrument, and a menu of multiplex PCR kits (respiratory pathogens, influenza, UTI, STD, HPV, antibiotic resistance) compatible with major third-party qPCR platforms (ABI, QuantStudio, Bio-Rad). The company also distributes BeDia Genomics' NIMoTest non-invasive prenatal RHD test in the US and operates the Favorgen/FavorPrep/FavorFilter sub-brands for manual extraction workflows.

The company earns revenue through three streams: (1) capital equipment sales of automated instruments to high-complexity laboratories, (2) consumable sales of DNA/RNA extraction kits and multiplex PCR kits (recurring revenue tied to instrument installed base), and (3) professional clinical testing services delivered through a physician portal and direct-to-consumer walk-in/drive-thru testing for COVID/Flu, respiratory pathogens, UTI, STD, HPV, and pharmacogenomics, with results typically returned within 24 hours. LabTurbo is an affiliated enterprise of Taigen Bioscience Corporation, is headquartered in Princeton, NJ with operating roots in Taiwan, and exports 80% of AIO 48 production to the United States, Philippines, Spain, Romania, and Czech Republic. The company is led by CEO Eric Dai and holds proprietary patents on its automated nucleic acid extraction system, ISO 13485 certification, and multiple government recognitions including the 2022 Outstanding Biotech Industry Award and the 2020 MOHW/MOEA Pharmaceutical Science and Technology Research Silver Award.

Name

LabTurbo Biotech

Legal name

LabTurbo Biotech Corporation

Website

https://labturbo.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

LabTurbo Biotech is a molecular diagnostics company that manufactures fully automated nucleic acid extraction and qPCR instruments, multiplex PCR kits, and extraction consumables for high-complexity clinical laboratories, and operates clinical PCR testing services for healthcare providers and consumers in the US.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Instruments and Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Molecular diagnostics systems
• Automated nucleic acid extraction
• QPCR detection platforms
• Multiplex PCR kits
• Clinical PCR testing

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Automated Instruments and Systems: Sale of automated molecular extraction and qPCR platforms including AIO 48, QuadAIO, and 48 Extraction Systems. These are capital equipment purchases for high-complexity laboratories.
2. DNA/RNA Extraction Kits: Consumable reagent kits for nucleic acid extraction including viral, stool, forensic, and plasmid extraction. Sold as individual kits and product families.
3. PCR Detection Kits: Multiplex PCR kits for respiratory pathogens, UTI, STD, HPV, antibiotic resistance, and other diagnostics. Available in 96-well and 384-well formats.
4. Clinical Testing Services: Direct diagnostic PCR testing services for healthcare providers and patients. Services include COVID/Flu, respiratory pathogens, UTI, STD, GI, pneumonia, HPV, and pharmacogenomics testing with 24-hour turnaround.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

LabTurbo Biotech designs, manufactures, and sells automated molecular diagnostic instruments and qPCR platforms for high-complexity clinical laboratories, complemented by multiplex PCR detection kits and DNA/RNA extraction consumables. The company also provides direct clinical PCR testing services (COVID/Flu, respiratory, STD, UTI, HPV, PGx) to physicians and self-pay patients through its US-based Princeton, NJ facility.

Product overview

LabTurbo Biotech offers a comprehensive molecular diagnostics portfolio consisting of fully automated instruments, PCR detection kits, DNA/RNA extraction kits, and clinical testing services. The automation instrument lineup includes the flagship AIO 48 SP-qPCR System for end-to-end sample-to-report automation, the 48 Extraction System for nucleic acid isolation, the QuadAIO System for point-of-care random-access testing, and the VacEZor for manual workflows. Their PCR kit portfolio covers respiratory pathogens (RP), influenza, urinary tract infections (UTI), antibiotic resistance (ABR), sexually transmitted infections (STD), and HPV—compatible with major qPCR platforms. The company also distributes Favorgen-branded manual extraction kits and provides direct clinical testing services for COVID/Flu/RSV, respiratory pathogens, STDs, UTIs, pharmacogenomics (PGx), and HPV. All products are manufactured under ISO 13485 quality standards.

Differentiator

Problem solved

Functional benefit

Brands

• Favorgen: Manual DNA/RNA extraction kits brand offering reliable, efficient extraction workflows for high-quality DNA and RNA purification, including plasmid, genomic, viral, tissue, blood, food, stool, soil, fungi, and plant extraction kits.
• FavorPrep
• FavorFilter

Products and services

• LabTurbo AIO 48 SP-qPCR System Fully automated high-throughput platform integrating sample barcode scanning, nucleic acid extraction, liquid handling, PCR setup, and result reporting for high-complexity clinical laboratories; processes 48 specimens/192 PCR wells per run with 5-channel multiplex PCR (up to 960 targets) and up to 1,000 tests in 24 hours.
• LabTurbo QuadAIO System Point-of-care random-access automation system with 5-channel qPCR, up to 50 targets per sample, and an independent 4-drawer design allowing simultaneous or independent testing in a compact walk-away format.
• LabTurbo 48 Extraction System End-to-end automated nucleic acid extraction system delivering high-yield, high-purity DNA/RNA from diverse sample types with minimal hands-on steps.
• LabTurbo VacEZor Manual Extraction System Vacuum-based manual DNA/RNA extraction system that simplifies traditional spin-column extraction, processing 36 samples in 30 minutes with reduced hands-on steps and cross-contamination.
• Respiratory Pathogen (RP) Multiplex PCR Kit Multiplex molecular assay for simultaneous detection of respiratory viruses and bacteria including SARS-CoV-2, influenza, RSV, and atypical pathogens.
• Common Flu Multiplex PCR Kit Multiplex PCR kit for simultaneous RNA detection of SARS-CoV-2, Influenza A, Influenza B, and RSV from upper respiratory tract specimens.
• UTI Multiplex PCR Detection Kit Multiplex PCR kit for qualitative detection of nucleic acids from 22 bacterial and fungal urinary pathogens in human urine specimens.
• ABR (Antibiotic Resistance) Multiplex PCR Detection Kit Multiplex PCR kit detecting resistance to beta-lactams (carbapenemases, ESBL, AmpC), vancomycin, macrolides, quinolones, sulfonamides, trimethoprim, and tetracyclines in a single run.
• STD Multiplex PCR Detection Kit Multiplex PCR kit for simultaneous detection of Chlamydia, Gonorrhea, Trichomonas, Mycoplasma genitalium, Herpes (HSV-1/2), Syphilis, and Chancroid from urine or swab specimens.
• HPV Multiplex PCR Detection Kit PCR kit detecting high-risk HPV types 16 and 18 associated with cervical cancer, supporting co-testing with Pap smear per CDC guidelines for women aged 30-65.
• NIMoTest Fetal RHD PCR Detection Kit Non-invasive prenatal test for fetal RHD genotyping from maternal blood using duplex real-time PCR detection of exons 5 and 7 of the RHD gene, distributed by LabTurbo in the US market.
• LabTurbo DNA Mini Kit (Genomic DNA) Fast, high-purity genomic DNA extraction kit from blood, saliva, tissue, and cell cultures, designed for full automation on LabTurbo systems.
• LabTurbo Viral DNA + RNA Mini Kit High-quality viral DNA, RNA, and cfDNA extraction kit from low-concentration samples such as plasma, serum, swabs, saliva, and tissue, optimized for automated workflows.
• LabTurbo Stool DNA + RNA Mini Kit DNA and RNA extraction kit optimized for challenging samples including stool, urine, soil, and wastewater, with enhanced impurity removal for improved assay sensitivity.
• LabTurbo Forensic DNA Mini Kit Fully automated extraction kit optimized for high-quality DNA from dry samples including buccal swabs, dried blood spots, and FTA cards, ideal for genotyping and STR analysis.
• Favorgen Manual DNA/RNA Extraction Kits Comprehensive line of manual extraction kits including plasmid, genomic DNA, total RNA, viral nucleic acid, and other specialized extraction kits for flexible small- to mid-volume workflows.
• COVID & Flu PCR Test (Clinical Service) Clinical PCR testing service for rapid detection of COVID-19 (SARS-CoV-2), Influenza A/B, and RSV from nasopharyngeal swab specimens with 24-hour result turnaround.
• Respiratory Pathogen (RP) PCR Test (Clinical Service) Comprehensive respiratory pathogen panel detecting coronaviruses, influenza, RSV, and bacteria such as Bordetella and Mycoplasma from nasopharyngeal swabs.
• STD PCR Test (Clinical Service) Clinical STD panel detecting Gonorrhea, Chlamydia, Mycoplasma Genitalium, Trichomonas Vaginalis, and HSV-1/2 from urine specimens with 24-hour turnaround.
• UTI PCR Test (Clinical Service) Clinical UTI testing with detection of bacterial and fungal pathogens plus antimicrobial resistance markers from urine specimens within 24 hours.
• PGx Testing Panel (Clinical Service) Pharmacogenomics testing panel covering 75+ medications across psychiatry, pain management, cardiology, and other specialties, using buccal cheek swab with results in 7-10 days.
• HPV PCR Test (Clinical Service) Clinical HPV testing for high-risk genotypes 16 and 18 using ThinPrep cervical samples, designed for women aged 30-65 as part of cervical cancer screening.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Institute of Preventive Medicine of National Defense Medical CentercoreStrategic or Co-development Partner · 1 December 2020Clinical cooperation partnership where researchers applied LabTurbo instruments for blind clinical experiments during the epidemic. The Institute was the first to use AIO 48 for epidemic prevention and helped LabTurbo obtain Taiwan TFDA Emergency Use Authorization (EUA). Their clinical evidence supported LabTurbo's successful entry into hospitals and pathogen screening institutions.
• Tri-Service General HospitalcoreStrategic or Co-development PartnerClinical partnership providing clinical evidence through Dr. Cai Shihong and group of doctors. Their clinical data validated LabTurbo products' effectiveness for virus detection and epidemic prevention.
• Taigen Bioscience CorporationcoreOthersLabTurbo is an affiliated enterprise of Taigen Bioscience Corporation, indicating corporate ownership or affiliation relationship.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Sansure Biotech: Chinese molecular diagnostics company with automated sample-to-result systems and a broad multiplex PCR menu (respiratory, STI, HPV). Comparable automation-plus-consumables model to LabTurbo with strong emerging-market reach.
• Qiagen: Qiagen's QIAcube and QIAsymphony automate nucleic acid extraction, and its PCR kits cover HPV, STI, and respiratory pathogens. Highly comparable extraction-to-PCR workflow and consumables model to LabTurbo's AIO platform and Favorgen kits.
• Cepheid (Danaher): Cepheid's GeneXpert system is the leading fully automated sample-to-result PCR platform for clinical diagnostics. Direct overlap with LabTurbo's AIO 48 in target customers (high-complexity labs), workflow (extraction-to-PCR), and menu (respiratory, STD, HPV).
• bioMérieux (BioFire): BioFire's FilmArray system is a leading sample-to-result multiplex PCR platform for respiratory, GI, and STI panels. Direct overlap with LabTurbo's RP Multiplex, UTI, STD, and GI panels in clinical lab customers.
• Bioneer: Korean molecular diagnostics company with the ExiStation and AccuPower multiplex PCR kits; similar size, product mix, and export-oriented footprint to LabTurbo, especially in Asia.

Broad incumbents

• Abbott Molecular: Abbott's m2000 and Alinity m systems provide automated sample preparation and real-time PCR in clinical labs. Targets the same high-complexity laboratory customers and respiratory/STD/HPV test menu as LabTurbo.
• Roche Diagnostics: Roche's cobas systems and broad IVD menu (including molecular diagnostics for HPV, CT/NG, respiratory viruses) compete with LabTurbo's instruments and kits across the same hospital lab and physician-office customers.
• Hologic: Hologic's Panther and Panther Fusion systems automate nucleic acid testing for women's health (HPV, CT/NG, Trichomonas), directly overlapping with LabTurbo's STD, HPV, and respiratory panels in clinical lab settings.

Emerging players

• ELITech Group: Mid-sized European IVD company offering sample preparation, real-time PCR kits, and clinical chemistry analyzers. Overlaps with LabTurbo on molecular sample prep and respiratory/STD/HPV kits for mid-volume labs.

Others

• Taigen Bioscience Corporation: Parent/affiliated enterprise of LabTurbo Biotech. Operates in overlapping molecular biology and life science research products space, providing corporate context for LabTurbo's ownership and capital structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/taigen-bioscience-corporation

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LabTurbo Biotech